HAI Book 2025 - Flipbook - Page 65
03:50 pm - 05:15 pm
SESSION IX Plasma Biomarkers: Application
Jasmeer Chhatwal, Massachusetts General
Hospital, Boston, MA, USA
Thomas Karikari, University of Pittsburgh,
Pittsburgh, PA, USA
03:50 pm - 03:55 pm
Session Overview
Chairs
03:55 pm
04:10 pm
Positive plasma A´42/40 despite negative
Amyloid PET: A harbinger of progression to
amyloid PET positivity?
Head-to-head association of plasma p-tau217
with MK6240, Flortaucipir, PI2620, and RO948
Tau PET Tracers
Azadeh Feizpour, Florey Institute of
Neuroscience and Mental Health, Melbourne, AU
Pamela Ferreira, University of Pittsburgh,
Department of Psychiatry, Pittsburgh, PA, US
04:25 pm
Modeling the temporal progression of plasma
and PET AD biomarkers with cognition
Petrice Cogswell, Mayo Clinic, Rochester, MN,
US
04:40 pm
Comparison of amyloid PET, tau PET, and
pTau217 biomarker progression between Down
syndrome and neurotypical adults with sporadic
Alzheimer9s disease
Matt Zammit, University of Wisconsin, Madison,
WI, US
04:55 pm - 05:15 pm
Discussion
05:15 pm - 05:25 pm
Awards Ceremony
HAI Executive Committee
5:25 pm – 5:30 pm
Concluding Remarks
Keith Johnson, Massachusetts General Hospital,
Boston, MA, USA
HAI2025 - 65
